Single-cell bloodstream infection diagnosis delivers rapid pathogen identification and antimicrobial susceptibility results from whole blood within hours, according to research published by S. M. Chin and colleagues in Science Advances. Bloodstream infections can progress to life-threatening sepsis, making rapid identification and effective antimicrobial treatment critical.
How STREAM Technology Accelerates Blood Culture Diagnostics
Conventional blood culture may require 2 to 7 days to produce definitive results. During that interim, medical professionals frequently turn to broad-spectrum empiric antibiotics, which run the risk of delivering substandard care or accelerating drug resistance.
To bypass these delays, researchers developed sedimentation-assisted tandem rocking and enrichment for analysis and monitoring, known as STREAM. According to the study published in Science Advances, this method combines bacterial enrichment with the removal of red blood cells from whole blood.
Whole blood is mixed with a customized culture broth and dextran before gentle rocking. Red blood cells clump together and sink due to the dextran, whereas bacteria remain floating in an upper layer rich in nutrients, where they carry on reproducing.
The remaining culture keeps incubating while periodic sample extractions take place, which helps maintain the capability to spot slow-growing microbes. The enriched bacteria are then analyzed using molecularly barcoded sequential fluorescence in situ hybridization.
Fluorescent probes targeting bacterial 16S ribosomal RNA identify pathogens at multiple taxonomic levels. Single bacterial cells are evaluated during antibiotic exposure via a distinct gel-based assay to establish susceptibility profiles alongside minimum inhibitory concentrations.
Did you know? Conventional blood culture may require 2 to 7 days to produce definitive results. While waiting for these outcomes, doctors typically administer empiric broad-spectrum antibiotics, a practice that might lead to suboptimal therapy or foster antimicrobial resistance.
High Concordance Rates with Clinical Laboratory Findings
Pathogen identification was assessed in 104 positive blood culture samples. The findings demonstrated a 96.15% alignment with reports from clinical microbiology laboratories, achieving identification within 1.2 to 2.5 hours.
Four samples were not fully resolved to the species level, but no organisms were misidentified. Across 219 combinations of antibiotics and doses, the single-cell antimicrobial susceptibility testing attained 97.96% essential agreement and 93.9% categorical agreement alongside clinical laboratory outcomes.
Total timeframes to full results spanned 6.75 to 17 hours when testing whole blood samples spiked with clinical isolates, with the duration varying based on the specific organism and its concentration. The average turnaround time was approximately 9 hours.
Clinical Translation and Path Forward
The findings suggest that rapid bloodstream infection diagnosis could support earlier targeted therapy and diagnostic stewardship. However, direct whole blood testing used spiked samples rather than prospective clinical specimens.
Previous antibiotic exposure, polymicrobial infections, intracellular organisms, and pathogens requiring specialized culture conditions may also impair detection.
The workflow involves several processing and imaging steps that could increase laboratory cost and complexity. Automation, broader pathogen coverage, and multicenter clinical studies will therefore be needed before routine implementation.
Pro Tip: For deeper insights into emerging laboratory technologies and antimicrobial stewardship, explore our latest analysis on resistance patterns and diagnostic innovations.
Frequently Asked Questions
How fast is the single-cell bloodstream infection diagnosis?
Based on findings shared in Science Advances, pathogen identification finishes in 1.2 to 2.5 hours, and full results for clinical-isolate-spiked whole blood specimens emerge within 6.75 to 17 hours, culminating in a mean turnaround duration of roughly 9 hours.
What is STREAM technology?
STREAM stands for sedimentation-assisted tandem rocking and enrichment for analysis and monitoring. The method combines bacterial enrichment with the removal of red blood cells from whole blood.
Is this diagnostic method currently used in hospitals?
Automation, broader pathogen coverage, and multicenter clinical studies will therefore be needed before routine implementation.
Join the Conversation: What are your thoughts on integrating single-cell diagnostics into emergency hospital workflows? Leave a comment below or subscribe to our newsletter for updates on clinical microbiology advancements.
- Amazon Labor Day Sale: Best Budget Workout Machine Deals
- Genetic Clusters Found in Autoimmune Diseases
- Mimicking Polycystic Liver Disease: A Novel Case of Multifocal Pancreatic Neuroendocrine Tumour-Induced Hepatic Metastases Diagnosed via Endoscopic Ultrasound – A Diagnostic Challenge and Treatment Opportunity” Keywords: – Polycystic Liver Disease – Pancreatic Neuroendocrine Tumour – Hepatic Metastases – Endoscopic Ultrasound – Multifocal Hepatic Cysts – Pancreatic Neuroendocrine Tumour Liver Metastasis – EUS in Hepatic Metastasis Diagnosis – Liver Metastasis from Pancreatic Tumours – Polycystic Liver Disease Diagnosis (archyworldys.com)